Inimur (Nifuratel)

Nifuratel exerts its antimicrobial effect by inhibiting microbial DNA synthesis and disrupting cell‑membrane function. This dual action interferes with the replication of bacteria and fungi, leading to their death and providing both antibacterial and antifungal activity within the vaginal environment.

The dosage regimen for Inimur is determined by the prescribing healthcare professional based on the specific infection, severity and patient characteristics. Patients should follow the prescriber’s instructions and the product label; no standard dose is provided here.

Safety data for Nifuratel in pregnancy and lactation are limited. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To order Inimur, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

The most common alternative for vaginal infections is metronidazole, a nitroimidazole. Compared with metronidazole, Nifuratel offers both antibacterial and antifungal activity, which can be advantageous in mixed infections. However, clinical choice depends on pathogen susceptibility, patient tolerance and local treatment guidelines.

Inimur should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat sources to maintain its stability and efficacy.

Inimur is administered intravaginally. The prescribed amount is inserted into the vagina using the supplied applicator or as directed by the healthcare professional, typically once or twice daily for the duration specified by the prescriber.

Serious adverse reactions, although rare, include allergic responses such as rash, swelling or anaphylaxis, severe vaginal inflammation or ulceration, and hepatic dysfunction indicated by abnormal liver enzymes. Patients should seek immediate medical attention if any of these symptoms occur.

Inimur should be avoided in individuals with known hypersensitivity to Nifuratel or other nitrofurans, in pregnant women unless clearly necessary, and in patients with severe liver disease where drug metabolism may be impaired. Consultation with a healthcare professional is essential before use.